Factor v Leiden (G1691A) and prothrombin-G20210A alleles among patients with deep venous thrombosis and in the general population from Spain;Comparación de las frecuencias de los alelos factor v Leiden (G1691A) y protrombina-G20210A entre pacientes con trombosis venosa profunda y población general mediterránea española

Revista Medica de Chile

Volumn 134, Issue 1, 2006, Pages 13-20

  Francès, Francesc ^a   Portolès, Olga ^a   Gabriel, Francisco ^b   Corella, Dolores ^a   Sorlí, José Vicente ^a   Sabater, Antonio ^a   Alfonso, José L ^a   Guillén, Marisa ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Alleles; Factor V Leiden; G20210A; Prothrombin gene; Venous thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

COMPARATIVE STUDY; FEMALE; GENE FREQUENCY; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; MALE; MULTIVARIATE ANALYSIS; REVIEW; RISK FACTOR; SPAIN; VEIN THROMBOSIS;

FACTOR V; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MULTIVARIATE ANALYSIS; PROTHROMBIN; RISK FACTORS; SPAIN; VENOUS THROMBOSIS;

EID: 33644689927     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Zivelin A, Griffin JH, Xu X, Pabinger I, Samama M, Conard J et al. A single genetic origin for a common Caucasian risk factor for venous thrombosis. Blood 1997; 89: 397-402.
2. Rees DC, Chapman NH, Webster NT, Guerreiro JF, Rochette J, Clegg JB. Born to clot: the European burden. Br J Haematol 1999; 105: 564-6.
3. Gardner J. Factor V Leiden with deep venous thrombosis. Clin Lab Sci 2003; 16: 6-9.
4. Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 1995; 85: 1504-8.
5. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-703.
6. Girolami A, Simioni P, Scarano L, Carraro G. Prothrombin and the prothrombin 20210 G to A polymorphism: their relationship with hypercoagulability and thrombosis. Blood Rev 1999; 13: 205-10.
7. Bonduel M, Hepner M, Sciuccati G, Pieroni G, Feliu-Torres A, Mardaraz C et al. Factor V Leiden and prothrombin gene G20210A mutation in children with venous thromboembolism. Thromb Haemost 2002; 87: 972-7.
8. Souto JC, Coll I, Llobet D, del Rio E, Oliver A, Mateo J et al. The prothrombin 20210A allele is the most prevalent genetic risk factor for venous thromboembolism in the Spanish population. Thromb Haemost 1998; 80: 366-9.
9. Aznar J, Vaya A, Estelles A, Mira Y, Segui R, Villa P et al. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives. Haematologica 2000; 85: 1271-6.
10. Lucotte G, Mercier G. Population genetics of factor V Leiden in Europe. Blood Cells Mol Dis 2001; 27: 362-7.
11. Sorli JV, Velert R, Guillen M, Portoles O, Ramírez JB, Iborra J et al. Efecto del polimorfismo de la Apolipoproteína E en el perfil lipoproteico y riesgo cardiovascular en una población mediterránea. Med Clin 2002; 118: 569-74.
12. Gabriel F, Labios M, Portoles O, Guillen M, Corella D, Frances F et al. Incidence of post-thrombotic syndrome and its association with various risk factors in a cohort of Spanish patients after one year of follow-up following acute deep venous thrombosis. Thromb Haemost 2004; 92: 328-36.
13. Sambrook J, Frotsch EF, Maniatis T. In: Ford N, Nolan C, Ferguson M, editors. Molecular cloning. Plainview, NY: Cold Spring Harbor Laboratory Press; 1989.
14. Hessner MJ, Luhm RA, Pearson SL, Endean DJ, Friedman KD, Montgomery RR. Prevalence of prothrombin G20210A, factor V G1691A (Leiden), and methylenetetrahydrofolate reductase (MTHFR) C677T in seven different populations determined by multiplex allele-specific PCR. Thromb Haemost 1999; 81: 733-8.
15. Mansilha A, Araujo F, Sampaio S, Cunha Ribeiro LM, Braga A. The PORtromb Project: prothrombin G20210A mutation and venous thromboembolism in young people. Cardiovasc Surg 2002; 10: 45-8.
16. Vargas M, Soto I, Pinto CR, Urgelles MF, Batalla A, Rodriguez-Reguero J et al. The prothrombin 20210A allele and the factor V Leiden are associated with venous thrombosis but not with early coronary artery disease. Blood Coagul Fibrinolysis 1999; 10: 39-41.
17. Margaglione M, Brancaccio V, De Lucia D, Martinelli I, Ciampa A, Grandone E et al. Inherited thrombophilic risk factors and venous thromboembolism: distinct role in peripheral deep venous thrombosis and pulmonary embolism. Chest 2000; 118: 1405-11.
18. Akar N, Misirlioglu M, Akar E, Aveu F, Yalcin A, Sozuoz A. Prothrombin gene 20210 G-A mutation in the Turkish population. Am J Hematol 1998; 58: 249.
19. Angelopoulou K, Nicolaides A, Constantinou Deltas C. Prevalence of genetic mutations that predispose to thrombophilia in a Greek Cypriot population. Clin Appl Thromb Hemost 2000; 6: 104-7.
20. Keenan C, Livingstone WJ, White B, Mynett-Johnson L, Cusack S, Lawler M et al. Prevalence of the prothrombin G20210A mutation in the Irish populations: use of a novel polymerase chain reaction approach. Blood Coagul Fibrinolysis 2000; 11: 669-72.
21. Lindmarker P, Schulman S, Sten-Linder M, Wiman B, Egberg N, Johnsson H. The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in the prothrombin gene. DURAC Trial Study Group. Duration of Anticoagulation. Thromb Haemost 1999; 81: 684-9.
22. Lucotte G, Mercier G. Frequency of factor V Leiden (Arg506Gln) in France. Br J Haematol 1997; 99: 237-41.
23. Garcia-Gala JM, Alvarez V, Pinto CR, Soto I, Urgelles MF, Menéndez MJ et al. Factor V Leiden (R506Q) and risk of venous thromboembolism: a case-control study based on the Spanish population. Clin Genet 1997; 52: 206-10.
24. Alvarez A, Barroso A, Robledo M, Arranz E, Outeirino J, Benítez J. Prevalence of factor V Leiden and the G20210A mutation of the prothrombin gene in a random group of patients with thrombotic episodes. Sangre 1999; 44: 7-12.
25. Schroder W, Koesling M, Wulff K, Wehnert M, Herrmann FH. Large-scale screening for factor V Leiden mutation in a north-eastern German population. Haemostasis 1996; 26: 233-6.
26. Tordai A, Klein I, Rajczy K, Pénzes M, Sarkadi B. Prevalence of factor V Leiden (Arg506Gln) in Hungary. Br J Haematol 1997; 99: 466-7.
27. De Stefano V, Voso MT, Chiusolo P, Paciaroni K, Bizzi B, Leone G. Prevalence of mutated factor V ARG506 to GLN in Italians. Thromb Haemost 1997; 77: 216-7.
28. Ferrer-Antunes C, Palmeiro A, Green F, Rosa H, Feliciano B, Silva E. Polymorphisms of fibrinogen, factor VII and factor V genes: Comparison of allele frequencies in different ethnic groups. Thromb Haemost 1995; 73: 1379.
29. Seligsohn U, Zivelin A. Thrombophilia as a multigenic disorder. Thromb Haemost 1997; 78: 297-301.
30. Richards MB, Macaulay VA, Bandelt HJ, Sykes BC. Phylogeography of mitochondrial DNA in western Europe. Ann Hum Genet 1998; 62: 241-60.
31. de Maat MP, Bladbjerg EM, Johansen LG, Gram J, Jespersen J. Absence of prothrombin mutation in Inuit (Greenland Eskimos) Thromb Haemost 1998; 79: 882.
32. Zabalegui N, Montes R, Orbe J, Ayape ML, Medarde A, Paramo JA et al. Prevalence of FVR506Q and prothrombin 20210A mutations in the Navarrese population. Thromb Haemost 1998; 80: 522-3.
33. Bauduer F, Ducout L, Freyburger G. Assessment of the 20210 G to A prothrombin variant in a sample of patients from the French Basque Country with various thrombophilic conditions. Ann Hematol 2003; 82: 353-6.
34. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346; 1133-4.
35. Arruda VR, von Zuben PM, Soares MCP, Menezes R, Annichino-Bizzacchi JM and Costa FF. Very low incidence of Arg506->Gln mutation in the factor V gene among the Amazonian Indians and the Brazilian Black population. Thromb Haemostasis 1996; 75: 859-63.
36. Gregg JP, Yamane AJ, Grody WW. Prevalence of the factor V-Leiden mutation in four distinct American ethnic populations. Am J Med Genet 1997; 19; 73: 334-6.
37. Margaglione M, Brancaccio V, Giuliani N, D'Andrea G, Cappucci G, Iannaccone L et al. Increased risk for venous thrombosis in carriers of the prothrombin G->A20210 gene variant. Ann Intern Med 1998; 129: 89-93.
38. Tosetto A, Missiaglia E, Frezzato M, Rodeghiero F. The VITA project: prothrombin G20210A mutation and venous thromboembolism in the general population. Thromb Haemost 1999; 82: 1395-8.
39. Girolami A, Simioni P, Manfrin D, Tormene D, Luni S. Asymptomatic homozygous nt 20210 G to A prothrombin polymorphism in two blood donors belonging to two different kindreds. Clin Appl Thromb Hemost 1999; 5: 48-51.
40. Khoury MJ, Yang Q. The future of genetic studies of complex human diseases: an epidemiologic perspective. Epidemiology 1998; 9: 350-4.
41. Khoury MJ. Genetic epidemiology and the future of disease prevention and public health. Epidemiol Rev 1997; 19: 175-80.
42. Kohury MJ. Relationship between medical genetics and public health: changing the paradigm of disease prevention and the definition of a genetic disease. Am J Med Genet 1997; 71: 289-91.
43. Genoud V, Castañon M, Annichino-Bizzachi J, Korin J, Kordich L. Prevalence of three prothrombotic polymorphisms: factor V G1691A, Factor II G290210A and Methilenetetrahydrofolate reductase (MTHFR) C677T in Argentina. Thromb Res 2000; 1; 100: 127-31.
44. Adamczuk Y, Iglesias Varela ML, Forastiero R, Martinuzzo M, Cerrato G, Pombo G et al. Factor V Leiden and prothrombin G20210A variant are risk factors for venous thromboembolism in the Argentinean population. Thromb Haemost 2000; 83: 509-10.
45. Rosendaal FR, Doggen CJ, Zivelin A, Arruda VR, Aiach M, Siscovick DS et al. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 1998; 79: 706-8.
46. Arruda VR, Annichino-Bizzacchi JM, Goncalves MS, Costa FF. Prevalence of the prothrombin gene variant (nt20210A) in venous thrombosis and arterial disease. Thromb Haemost 1997; 78: 1430-3.
47. Herrmann FH, Koesling M, Schroder W, Altman R, Jiménez Bonilla R, Lopaciuk S et al. Prevalence of factor V Leiden mutation in various populations. Genet Epidemiol 1997; 14: 403-11.
48. Hepner M, Roldán A, Pieroni G, Frontroth JP, Serviddio RM, Torres AF et al. Factor V Leiden mutation in the Argentinian population. Thromb Haemost 1999; 81: 989.
49. Pereira J, Quiroga T, Goycoolea M, Muñoz B, Hidalgo P, Kaltwasser G et al. Resistencia a la proteína C activada: estudio de laboratorio y prevalencia del defecto en la población chilena. Rev Med Chile 1996; 124: 663-8.
50. Camacho Vanegas O, Giusti B, Restrepo Fernandez CM, Abbate R, Pepe G. Frequency of factor V (FV) Leiden and C677T methylenetetrahydrofolate reductase (MTHFR) mutations in Colombians. Thromb Haemost 1998; 79: 883-4.